Cantargia Strengthen Management Team with The Appointment of Ton Berkien as Chief Business Officer
LUND, SE / ACCESSWIRE / June 11, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA), today announced the strengthening...
Cancer
Global Registrational Phase III Study of Olverembatinib for the Treatment of Patients with SDH-Deficient GIST Approved by the China CDE
SUZHOU, China, and ROCKVILLE, Md., June 10, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing...
HealthPartners Institute receives $3.2M grant from National Cancer Institute to create and study new tool that will improve care for patients with genetic risk of cancer
The project, which leverages HealthPartners myGenetics community research database, will help primary care clinicians provide the latest screening recommendations to...
2024 American Oncology Annual Meeting Concludes in Chicago, CANCER CASES SURGE IN WESTERN COUNTRIES, Cancer Driver Interception: Active Prevention Strategy to Reduce Disease Burden
CHICAGO, June 10, 2024 /PRNewswire/ -- The 2024 edition of the American Society of Clinical Oncology (ASCO) Congress highlighted a...
ConcertAI Appoints Timothy Albury as Chief Financial Officer
CAMBRIDGE, Mass., June 10, 2024 /PRNewswire/ -- ConcertAI, the leader in oncology predictive and generative AI SaaS Solutions and Real-World...
Bulletin from the 2024 Annual General Meeting of Spago Nanomedical AB
LUND, SE / ACCESSWIRE / June 10, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) The Annual General Meeting (AGM) of Spago Nanomedical...
Goshen Hospital Achieves Magnet with Distinction(TM) Recognition
Goshen, Indiana--(Newsfile Corp. - June 10, 2024) - Magnet recognition is one of the highest honors a healthcare organization can...
Ruvidar(TM) Enhances Efficacy of Cancer Drug
TORONTO, ON / ACCESSWIRE / June 10, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...
AIM ImmunoTech to Participate in the Virtual Investor Pitch Conference
Live video webcast on Monday, June 17th at 1:00 PM ETOCALA, Fla., June 10, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech...
SELLAS Announces Completion of Enrollment and Initial Positive Data in Phase 2a Trial of SLS009 in r/r AML
- 30 Patients Relapsed or Refractory to Venetoclax-Based Regimens Enrolled Ahead of Schedule - - Overall Response Rate (ORR) of...
Twelve month Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis (FAP) to be Presented at Prestigious Biennial InSIGHT 2024 Meeting in Barcelona
June 10, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Twelve month Phase 2 Clinical Trial Results of eRapa™ in Familial...
Veru to Present at the American Diabetes Association’s 84th Scientific Sessions
MIAMI, FL, June 10, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on...
RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships
New role highlights RenovoRx’s commitment to explore and execute on clinical and commercial business development opportunities with its therapeutic technologyLOS...
Defence to Participate in 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting in Toronto on June 11, 2024
Vancouver, British Columbia--(Newsfile Corp. - June 10, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), ("Defence" or...
Akero Therapeutics Presents Poster and Late-breaking Oral Presentation on EFX at the EASL Congress 2024
SOUTH SAN FRANCISCO, Calif., June 08, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage biotechnology company developing...
Seniors in Metro Vancouver Invited to Participate in a Clinical Trial Assessing a New Immunomodulator Designed to Restore Immune Function in the Elderly
Vancouver, BC, June 07, 2024 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a Burnaby-based clinical-stage biotechnology company, is pleased to announce...
Calyx / Invicro Forges a Strategic Collaboration with BAMF Health to Accelerate Clinical Translation of Radioligand Therapies and Immuno-Oncology Agents
LONDON and BOSTON, June 7, 2024 /PRNewswire/ -- Calyx / Invicro, a global leader in providing medical imaging solutions and...
GE HealthCare Increases Access to Precision Care Tools, Encouraging the Continued Adoption and Practice of More Personalized Medicine Around the World
At #SNMMI24, GE HealthCare expands its technology with the addition of a MINItrace Magni,i designed to be a small footprint...
IONETIX Produces First Batch of Actinium-225
LANSING, Mich., June 7, 2024 /PRNewswire/ -- IONETIX, a leading cyclotron technology innovator, isotope producer, and radiopharmaceutical manufacturer, announced today...
Edgepark launches new e-Ordering platform for healthcare providers
Edgepark opens the first ostomy storefront available nationwide through Parachute Health TWINSBURG, Ohio, June 7, 2024 /PRNewswire/ -- Edgepark announced...